Theravance Biopharma Inc. (TBPH)
NASDAQ: TBPH
· Real-Time Price · USD
13.14
0.20 (1.55%)
At close: Aug 15, 2025, 3:59 PM
13.16
0.15%
After-hours: Aug 15, 2025, 06:33 PM EDT
Theravance Biopharma Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 65.27M | 64.38M | 63.19M | 62.02M | 61.51M | 57.42M | 54.51M | 51.27M | 48.57M | 51.35M | 51.64M | 52.38M | 54.25M | 55.31M | 59.09M | 64.16M | 66.25M |
Cost of Revenue | n/a | n/a | 4.33M | 5.67M | 7.01M | 8.67M | 5.58M | 5.87M | 6.76M | 6.59M | 36.57M | 78.68M | 127.54M | 193.66M | 227.6M | 251.23M | 262.54M |
Gross Profit | 65.27M | 64.38M | 58.86M | 56.34M | 54.5M | 48.76M | 48.93M | 45.4M | 41.8M | 44.76M | 15.07M | -26.3M | -73.29M | -138.35M | -168.5M | -187.07M | -196.29M |
Operating Income | -50.18M | -46.95M | -43.99M | -41.91M | -42.33M | -56.03M | -67.23M | -72.67M | -49.69M | -63.28M | -102.01M | -141.43M | -212.39M | -257.78M | -278.11M | -301.11M | -309.17M |
Interest Income | 4.39M | 4.88M | 5.82M | 6.2M | 7.57M | 9.12M | 10.99M | 11.96M | 11.9M | 8.92M | 5.54M | 2.78M | 1.51M | 1.51M | 1.97M | 3.08M | 2.98M |
Pretax Income | -48.35M | -44.61M | -40.69M | -38.22M | -37.19M | -49.27M | -58.51M | -66.95M | -60.96M | -63.9M | -81.83M | -101.12M | -145.55M | -199.58M | -234.63M | -272.86M | -283.08M |
Net Income | -58.33M | -56.42M | -49.4M | -45.65M | -44.77M | -55.19M | -60.94M | 864.64M | 872.09M | 868.24M | 850.46M | -101.48M | -145.69M | -199.43M | -225.83M | -264.16M | -274.64M |
Selling & General & Admin | 70.8M | 69.17M | 66.17M | 65.43M | 67.65M | 70.09M | 71.34M | 71.47M | 69.18M | 73.64M | 78.42M | 83.44M | 92.38M | 99.3M | 107.83M | 114.04M | 112.89M |
Research & Development | 40.13M | 37.64M | 36.5M | 35.55M | 35.02M | 40.62M | 47.66M | 49.21M | 55.36M | 64.04M | 79.92M | 113.79M | 149.31M | 193.66M | 227.6M | 251.23M | 262.54M |
Other Expenses | 4.51M | 4.51M | 4.51M | 2.95M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 126K | -1.61M |
Operating Expenses | 115.44M | 111.33M | 107.18M | 103.93M | 102.67M | 110.72M | 118.99M | 120.68M | 124.54M | 137.67M | 158.33M | 197.23M | 241.69M | 292.95M | 335.43M | 365.26M | 375.43M |
Interest Expense | 2.56M | 2.55M | 2.53M | 2.5M | 2.43M | 2.35M | 2.28M | 3.21M | 4.78M | 16.26M | 27.37M | 37.74M | 47.21M | 47.29M | 47.31M | 46.97M | 46.75M |
Selling & Marketing Expenses | n/a | n/a | 5.1M | 5.1M | 5.1M | 5.1M | 8M | 8M | 8M | 8M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 115.44M | 111.33M | 107.18M | 103.93M | 102.67M | 110.72M | 118.99M | 120.68M | 124.54M | 137.67M | 158.33M | 197.23M | 241.69M | 292.95M | 335.43M | 365.26M | 375.43M |
Income Tax Expense | 9.98M | 11.8M | 8.71M | 7.43M | 7.58M | 5.92M | 2.43M | 1.06M | -403K | 516K | 368K | 361K | 146K | -151K | -8.8M | -8.7M | -8.44M |
Shares Outstanding (Basic) | 49.71M | 49.31M | 49.04M | 48.75M | 48.28M | 49.41M | 52.36M | 56.68M | 62.93M | 67.39M | 75.52M | 76.27M | 75.25M | 73.62M | 73.57M | 65.67M | 64.49M |
Shares Outstanding (Diluted) | 49.71M | 49.31M | 49.04M | 48.75M | 48.28M | 49.41M | 52.36M | 56.68M | 62.93M | 67.39M | 75.52M | 76.27M | 75.25M | 73.96M | 73.57M | 65.67M | 64.49M |
EPS (Basic) | -1.18 | -1.15 | -1.01 | -0.92 | -0.86 | -0.97 | -1.01 | 11.30 | 11.47 | 11.48 | 11.25 | -1.37 | -2.06 | -2.96 | -3.44 | -4.12 | -4.32 |
EPS (Diluted) | -1.18 | -1.15 | -1.01 | -0.92 | -0.86 | -0.97 | -1.01 | 11.30 | 11.47 | 11.48 | 11.26 | -1.36 | -2.05 | -2.95 | -3.44 | -4.12 | -4.32 |
EBITDA | -42.3M | -38.45M | -33.53M | -30.5M | -29.18M | -40.87M | -50.66M | -57.87M | -64.75M | -82.98M | -90.01M | -130.77M | -150.23M | -177.03M | -211.95M | -218.16M | -228.43M |
EBIT | -45.79M | -42.07M | -38.16M | -35.72M | -34.76M | -46.92M | -56.23M | -63.74M | -46.43M | -61.72M | -68.54M | -107.67M | -152.37M | -182.5M | -217.53M | -225.89M | -236.33M |
Depreciation & Amortization | 3.49M | 3.62M | 4.64M | 5.22M | 5.58M | 6.05M | 5.58M | 5.87M | 6.76M | 6.59M | 6.37M | 7.38M | 7.54M | 8.34M | 9.79M | 9.14M | 9M |